On Saturday, December 4, 2021, starting at 10:00 p.m. EST we will be launching the New FAST Graphs. This may cause temporary interruptions. We are sorry for any inconvenience this may cause.

Cardinal Health (CAH)

40 Consistent Attractively Valued Dividend Growth Stocks

2021-09-16

Research Articles

Dividend Growth Stocks I am constantly being asked to provide a list of high-quality consistent dividend growth stocks.  Consequently, I conducted a search and came up with 40 dividend growth stocks that I feel are worthy of further research and due diligence.  These companies have consistent long-term operating history and solid prospects for future growth.  […]

Owens & Minor: A Treacherous Path To 10% Returns

2020-10-09

Research Articles

Introduction On January 26, 2018, I wrote an article titled: “Owens & Minor Inc.: Irresistible Yield, Irresistible Valuation” where I offered the company as an extremely undervalued Dividend Contender research candidate. I also pointed out that the company was in transformation. However, I underestimated what that transformation meant, at least over the short run. I […]

Cardinal Health Update-A Dividend Aristocrat on Sale

2020-04-16

Research Articles

Introduction On November 22, 2017, I published an article titled: “Cardinal Health: A Dividend Aristocrat the Risk Is Already Priced In.”  At that time, Cardinal Health (CAH) was trading at approximately $56 per share and was paying a dividend of $1.81 representing a dividend yield of about 3.1%.  Of course, a lot has changed with […]

The S&P 500 is Overvalued These 10 Dividend Growth Stocks Are Not: Part 3

2018-04-13

Research Articles

Introduction This is the third of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value.  With this article I will be covering 10 additional dividend growth research candidates with moderate to higher yields in addition to the initial 20 that I presented in part 1 found here and […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.